Abstract 6487: Exploratory study of camrelizumab combined with chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: Shandong Tumor Hospital, Shandong First Medical University
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148878142
Cites:
Cited by:
Related to: